Report Detail
Global (United States, European Union and China) Ophthalmic Drugs Market Research Report 2019-2025
- RnM3682868 |
- 19 August, 2019 |
- Global |
- 118 Pages |
- QYResearch |
- Pharma & Healthcare
Ophthalmic drugs are extensively used to treat glaucoma, cataract, diabetic retinopathy, and other ophthalmic disorders. Introduction of novel ocular drug delivery approaches in the market has driven the manufacturers to develop innovative therapeutic approaches for the treatment of ophthalmic disorders.
The other key factors that boost the ophthalmic drug market size include high prevalence of glaucoma worldwide and rise in transition towards development of combination therapies for the treatment of glaucoma.
According to the American Academy of Ophthalmology over 27.1 million of North American population is suffering from Primary Open Angle Glaucoma (POAG) and this number is constantly rising. Thus, increasing eye disorders is fueling the growth of the global ophthalmic drugs market.
It was reported that around two-third of the population in the Asia Pacific region are blind or vision impaired. Moreover, development of various novel technologies in developing markets such as China & India is expected to improve healthcare facilities.
In 2019, the market size of Ophthalmic Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Ophthalmic Drugs.
This report studies the global market size of Ophthalmic Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Ophthalmic Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Santen Pharmaceutical
Valeant Pharmaceuticals
Shire
Novartis
Genentech
Allergan
Sun Pharmaceutical Industries
Actavis Generics
Regeneron Pharmaceuticals
Pfizer
Johnson and Johnson
Bausch and Lomb
Market Segment by Product Type
Anti-allergy
Anti-VEGF Agents
Anti-inflammatory
Anti-glaucoma
Market Segment by Application
Hospital
Clinic
Pharmacy
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Ophthalmic Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Ophthalmic Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Ophthalmic Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Ophthalmic Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Anti-allergy
- 1.3.3 Anti-VEGF Agents
- 1.3.4 Anti-inflammatory
- 1.3.5 Anti-glaucoma
- 1.4 Market Segment by Application
- 1.4.1 Global Ophthalmic Drugs Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Pharmacy
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Ophthalmic Drugs Market Size
- 2.1.1 Global Ophthalmic Drugs Revenue 2014-2025
- 2.1.2 Global Ophthalmic Drugs Sales 2014-2025
- 2.2 Ophthalmic Drugs Growth Rate by Regions
- 2.2.1 Global Ophthalmic Drugs Sales by Regions 2014-2019
- 2.2.2 Global Ophthalmic Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Ophthalmic Drugs Sales by Manufacturers
- 3.1.1 Ophthalmic Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Ophthalmic Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Ophthalmic Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Ophthalmic Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Ophthalmic Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Ophthalmic Drugs Price by Manufacturers
- 3.4 Key Manufacturers Ophthalmic Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Ophthalmic Drugs Market
- 3.6 Key Manufacturers Ophthalmic Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Anti-allergy Sales and Revenue (2014-2019)
- 4.1.2 Anti-VEGF Agents Sales and Revenue (2014-2019)
- 4.1.3 Anti-inflammatory Sales and Revenue (2014-2019)
- 4.1.4 Anti-glaucoma Sales and Revenue (2014-2019)
- 4.2 Global Ophthalmic Drugs Sales Market Share by Type
- 4.3 Global Ophthalmic Drugs Revenue Market Share by Type
- 4.4 Ophthalmic Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Ophthalmic Drugs Sales by Application
6 United States
- 6.1 United States Ophthalmic Drugs Breakdown Data by Company
- 6.2 United States Ophthalmic Drugs Breakdown Data by Type
- 6.3 United States Ophthalmic Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Ophthalmic Drugs Breakdown Data by Company
- 7.2 European Union Ophthalmic Drugs Breakdown Data by Type
- 7.3 European Union Ophthalmic Drugs Breakdown Data by Application
8 China
- 8.1 China Ophthalmic Drugs Breakdown Data by Company
- 8.2 China Ophthalmic Drugs Breakdown Data by Type
- 8.3 China Ophthalmic Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Ophthalmic Drugs Breakdown Data by Company
- 9.2 Rest of World Ophthalmic Drugs Breakdown Data by Type
- 9.3 Rest of World Ophthalmic Drugs Breakdown Data by Application
- 9.4 Rest of World Ophthalmic Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Ophthalmic Drugs Sales by Countries
- 9.4.2 Rest of World Ophthalmic Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Santen Pharmaceutical
- 10.1.1 Santen Pharmaceutical Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Ophthalmic Drugs
- 10.1.4 Ophthalmic Drugs Product Introduction
- 10.1.5 Santen Pharmaceutical Recent Development
- 10.2 Valeant Pharmaceuticals
- 10.2.1 Valeant Pharmaceuticals Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Ophthalmic Drugs
- 10.2.4 Ophthalmic Drugs Product Introduction
- 10.2.5 Valeant Pharmaceuticals Recent Development
- 10.3 Shire
- 10.3.1 Shire Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Ophthalmic Drugs
- 10.3.4 Ophthalmic Drugs Product Introduction
- 10.3.5 Shire Recent Development
- 10.4 Novartis
- 10.4.1 Novartis Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Ophthalmic Drugs
- 10.4.4 Ophthalmic Drugs Product Introduction
- 10.4.5 Novartis Recent Development
- 10.5 Genentech
- 10.5.1 Genentech Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Ophthalmic Drugs
- 10.5.4 Ophthalmic Drugs Product Introduction
- 10.5.5 Genentech Recent Development
- 10.6 Allergan
- 10.6.1 Allergan Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Ophthalmic Drugs
- 10.6.4 Ophthalmic Drugs Product Introduction
- 10.6.5 Allergan Recent Development
- 10.7 Sun Pharmaceutical Industries
- 10.7.1 Sun Pharmaceutical Industries Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Ophthalmic Drugs
- 10.7.4 Ophthalmic Drugs Product Introduction
- 10.7.5 Sun Pharmaceutical Industries Recent Development
- 10.8 Actavis Generics
- 10.8.1 Actavis Generics Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Ophthalmic Drugs
- 10.8.4 Ophthalmic Drugs Product Introduction
- 10.8.5 Actavis Generics Recent Development
- 10.9 Regeneron Pharmaceuticals
- 10.9.1 Regeneron Pharmaceuticals Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Ophthalmic Drugs
- 10.9.4 Ophthalmic Drugs Product Introduction
- 10.9.5 Regeneron Pharmaceuticals Recent Development
- 10.10 Pfizer
- 10.10.1 Pfizer Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Ophthalmic Drugs
- 10.10.4 Ophthalmic Drugs Product Introduction
- 10.10.5 Pfizer Recent Development
- 10.11 Johnson and Johnson
- 10.12 Bausch and Lomb
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Ophthalmic Drugs Sales Channels
- 11.2.2 Ophthalmic Drugs Distributors
- 11.3 Ophthalmic Drugs Customers
12 Market Forecast
- 12.1 Global Ophthalmic Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Ophthalmic Drugs Sales Forecast by Type
- 12.3 Global Ophthalmic Drugs Sales Forecast by Application
- 12.4 Ophthalmic Drugs Forecast by Regions
- 12.4.1 Global Ophthalmic Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Ophthalmic Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Ophthalmic Drugs. Industry analysis & Market Report on Ophthalmic Drugs is a syndicated market report, published as Global (United States, European Union and China) Ophthalmic Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Ophthalmic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
